PORTON BIOPHARMA - Trademark Details
Status: 700 - Registered
Serial Number
79180318
Registration Number
5288111
Word Mark
PORTON BIOPHARMA
Status
700 - Registered
Status Date
2017-09-19
Filing Date
2015-09-04
Registration Number
5288111
Registration Date
2017-09-19
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260117, 260121, 260129 - Two concentric circles. Circles that are totally or partially shaded. Helixes.
Published for Opposition Date
2017-07-04
Attorney Name
Law Office Assigned Location Code
N20
Employee Name
ROSENBLATT, ANNA HASSE
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOPHARMA"
Description of Mark
The mark consists of the stylized wording "PORTON" written above the stylized wording "BIOPHARMA". To the left of the wording is a helix inside two shaded concentric circles.
Goods and Services
Pharmaceutical preparations, namely, biologics and biopharmaceuticals in the form of vaccines, blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors, therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue used to protect against infectious disease and to treat cancers, rheumatoid diseases and disorders, skin diseases and disorders, immune system diseases and disorders, anemia and diseases of the blood, gastrointestinal diseases and disorders, and neurological diseases and disorders; sanitary preparations for medical purposes; plasters for medical purposes as materials for dressings; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical preparations and substances in the nature of vaccines and blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors, therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue; injectable pharmaceutical compositions and preparations comprising compounds having asparaginase activity for treatment of leukaemia; pharmaceutical compositions and preparations for the treatment of leukaemia and malignant diseases in the blood forming organs
Goods and Services
Education, namely, providing conferences, seminars, workshops, training, and exhibitions in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals and their development and manufacture, and the distribution of course materials in connection therewith; arrangement of conferences for educational purposes; advice relating to medical training; advisory services relating to training; advisory services relating to education; arranging and conducting of workshops in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; conducting instructional courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; conducting of educational seminars relating to medical matters; training courses relating to medicine; training courses relating to science; medical education services, namely, providing continuing medical education courses; medical training and teaching; organization of training courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; publication of books; writing of texts other than publicity texts; providing continuing dental education courses; providing continuing medical education courses; provision of educational information about medical education; provision of training in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; provision of training courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; provision of on-line electronic publications not downloadable from the Internet in the nature of newsletters, articles, e-books, and white papers in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; production of video-tapes for corporate use in corporate educational training; professional consultancy relating to education; publication of educational material in the nature of textbooks in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services for medical visitors in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services for nurses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services relating to health and safety; arranging and conducting of workshops relating to biologics; arranging and conducting of workshops relating to biopharmaceuticals; arranging and conducting training relating to biologics; arranging and conducting training relating to biopharmaceuticals; arrangement of workshops for educational purposes in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-01-14
Primary Code
005
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2016-01-14
Primary Code
041
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (PRIVATE LIMITED COMPANY).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (PRIVATE LIMITED COMPANY).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (PRIVATE LIMITED COMPANY).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (PRIVATE LIMITED COMPANY).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Julia C. Archer
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1282757
International Registration Date
2015-09-04
International Publication Date
2016-01-07
International Renewal Date
2025-09-04
Auto Protection Date
2018-06-08
International Status
001 - Request for extension of protection established
International Status Date
2016-01-07
Priority Claimed In
True
Priority Claimed Date
2015-03-04
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2016-01-07 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2016-01-12 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| 2016-01-14 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2016-01-14 | ASSIGNED TO EXAMINER |
| 2016-01-19 | APPLICATION FILING RECEIPT MAILED |
| 2016-01-21 | NON-FINAL ACTION WRITTEN |
| 2016-01-22 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2016-01-25 | REFUSAL PROCESSED BY MPU |
| 2016-01-25 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2016-02-13 | REFUSAL PROCESSED BY IB |
| 2016-07-25 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2016-07-29 | ASSIGNED TO LIE |
| 2016-08-05 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2016-08-05 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2016-08-26 | FINAL REFUSAL WRITTEN |
| 2016-08-26 | FINAL REFUSAL E-MAILED |
| 2016-08-26 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2016-11-18 | CORRECTION TRANSACTION RECEIVED FROM IB |
| 2016-12-09 | CORRECTION TRANSACTION RECEIVED FROM IB |
| 2016-12-22 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| 2016-12-22 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| 2016-12-27 | ATTORNEY REVIEW COMPLETED |
| 2017-02-27 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2017-02-27 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2017-02-27 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2017-03-09 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2017-03-16 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2017-03-28 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| 2017-04-07 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| 2017-04-18 | NON-FINAL ACTION WRITTEN |
| 2017-04-18 | NON-FINAL ACTION E-MAILED |
| 2017-04-18 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2017-05-03 | EXAMINERS AMENDMENT -WRITTEN |
| 2017-05-03 | EXAMINERS AMENDMENT E-MAILED |
| 2017-05-03 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2017-05-03 | EXAMINER'S AMENDMENT ENTERED |
| 2017-05-05 | ASSIGNED TO EXAMINER |
| 2017-05-23 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2017-05-31 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 2017-06-14 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2017-06-14 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2017-06-14 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2017-07-01 | NOTIFICATION PROCESSED BY IB |
| 2017-07-04 | PUBLISHED FOR OPPOSITION |
| 2017-07-04 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2017-09-19 | REGISTERED-PRINCIPAL REGISTER |
| 2017-12-19 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2017-12-30 | FINAL DISPOSITION PROCESSED |
| 2017-12-30 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2018-01-26 | FINAL DECISION TRANSACTION PROCESSED BY IB |
